PROSE_2B | R Documentation |
Kaplan-Meier digitized data from PROSE, figure 2B (PMID 24831979). A reported sample size of 142 for a primary endpoint of OS in lung cancer.
PROSE_2B
A data frame of 263 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (chemo, erlotinib) | |
Gregorc V, Novello S, Lazzari C, et al. Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial. Lancet Oncol 2014; 15: 713–21.
summary(PROSE_2B)
kmplot(PROSE_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.